DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0011849 | Diabetes Mellitus | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0006142 | Malignant neoplasm of breast | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0020456 | Hyperglycemia | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0678222 | Breast Carcinoma | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0017919 | Glycogen Storage Disease | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0205734 | Diabetes, Autoimmune | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0020459 | Hyperinsulinism | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0021670 | insulinoma | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0085207 | Gestational Diabetes | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0271650 | Impaired glucose tolerance | G6PC2 | 57818 | glucose-6-phosphatase catalytic subunit 2 | Q9NQR9 |
C0524851 | Neurodegenerative Disorders | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0678222 | Breast Carcinoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0079773 | Lymphoma, T-Cell, Cutaneous | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C1332979 | Childhood Lymphoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C2931822 | Nasopharyngeal carcinoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0009402 | Colorectal Carcinoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0006826 | Malignant Neoplasms | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0036341 | Schizophrenia | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0017636 | Glioblastoma | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C1621958 | Glioblastoma Multiforme | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0024623 | Malignant neoplasm of stomach | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0158266 | Intervertebral Disc Degeneration | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
C0027651 | Neoplasms | TIGAR | 57103 | TP53 induced glycolysis regulatory phosphatase | Q9NQ88 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024